Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.77 USD
Change Today +0.01 / 0.21%
Volume 988.4K
OREX On Other Exchanges
Symbol
Exchange
Stuttgart
As of 8:10 PM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Joseph P. Hagan

Chief Business & Financial Officer and Treasurer, Orexigen Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 2 different organizations across 7 different industries.

See Board Relationships
46$1,707,150
As of Fiscal Year 2014

Background*

Mr. Joseph P. Hagan, also known as Jay, has been Chief Business & Financial Officer of Orexigen Therapeutics, Inc. since February 2015 and serves as its Treasurer. Mr. Hagan is the Founder of Access Bioventures. He served as Executive Vice President and Principal Accounting Officer at Orexigen Therapeutics, Inc., and also served as Acting Chief Financial Officer since March 2011 and Chief Business Officer since June 2011. Mr. Hagan served as Senior Vice President of ...

Read Full Background

Corporate Headquarters*

3344 North Torrey Pines Court
La Jolla, California 92037

United States

Phone: 858-875-8600
Fax: 858-875-8650

Board Members Memberships*

Member of Board of Directors
Director
Former Director
Former Director
Former Director
Former Director
2015-Present
Director

Education*

MBA
Northeastern University
BS
University of California - San Diego

Other Affiliations*

Annual Compensation*

Salary$379,250
Total Annual Compensation$379,250

Stock Options*

All Other Compensation$7,980
Exercisable Options1,069,323
Unexercisable Options579,674
Total Number of Options1,648,997

Total Compensation*

Total Annual Cash Compensation$565,478
Total Short Term Compensation$379,250
Other Long Term Compensation$7,980
Total Calculated Compensation$1,707,150
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OREX:US $4.77 USD +0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Arena Pharmaceuticals, Inc.
$746.8K
Seth H. Z. Fischer Chief Executive Officer, Chief Commercial Officer and Director
VIVUS Inc.
$650.0K
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OREXIGEN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.